RUNX1 was a candidate for a recurrent OAC driver (24% of patient samples, 92/383), uniquely affected by SVs, a known target of inter-chromosomal translocations in leukaemias, that has been shown to play a role either as an oncogene or TSG in a variety of cancer types35–37. The gene discussed is RUNX1; the disease is leukemia.